|
|||
|
Multiple Sclerosis Info
Search
This Month
|
Wednesday, May 31
by
All About MS
on Wed 31 May 2006 11:00 AM CST
Serono (drt-x: SEO and NYSE: SRA) announced today that recruitment in the U.S. is beginning for the Phase III CLARITY study (CLAdRIbine Tablets in Treating MS OrallY Study) of oral cladribine for the treatment of patients with relapsing forms of multiple sclerosis (MS). This multi-national study was successfully more »
by
All About MS
on Wed 31 May 2006 10:00 AM CST
Recent study outcomes suggest that among women with multiple sclerosis, the age of the first menstrual cycle may be associated with the age a woman experiences the first symptoms of MS.
To evaluate the affect of hormone changes during a first menstrual cycle on MS risk, the investigators sent a survey to 438 female patients with relapsing-remitting MS living in the provinces of Newfoundland and Labrador. Participants were asked more »
by
All About MS
on Wed 31 May 2006 09:18 AM CST
Multiple Sclerosis is an inflammatory disease of the central nervous system (CNS) that damages the insulating material that surrounds the nerve fibers in the brain, spinal cord, and nerves of the more »
Monday, May 29
by
All About MS
on Mon 29 May 2006 12:33 PM CST
Chromos Molecular Systems, Inc., (CHR) has signed a contract with AppTec Laboratory Services, Inc., (AppTec) for scale-up and manufacture of its monoclonal antibody drug product candidate CHR-1103.
Chromos has used its more »
Saturday, May 27
by
All About MS
on Sat 27 May 2006 05:43 AM CST
Recent study findings indicate that symptoms of overactive bladder syndrome appear to have more impact on the quality of life of women with MS than women without MS.
Symptoms of overactive bladder include more »
Friday, May 26
by
All About MS
on Fri 26 May 2006 03:00 AM CST
An editorial accompanying a published debate on the pros and cons of starting treatment early in the course of multiple sclerosis comes down in favour of early treatment for this potentially devastating disease. This opinion coincides with a consensus paper published by the National MS Society. The April issue of the Archives of Neurology features both sides of this debate on more »
Thursday, May 25
by
All About MS
on Thu 25 May 2006 12:00 AM CST
The first therapy that I will discuss is Glatiramer Acetate (Copaxone), because I have been asked a question about that therapy. Later I will write about the other therapies more »
Wednesday, May 24
by
All About MS
on Wed 24 May 2006 09:00 PM CST
Taking a course in energy conservation can significantly help MS patients avoid feelings of fatigue, according to data from a study published in the October issue of the journal Multiple Sclerosis.
The study, which included 169 participants with MS more »
Tuesday, May 23
by
All About MS
on Tue 23 May 2006 03:00 AM CST
Pregnant women with MS who deliver vaginally may have more complicated labors than women without MS, a new study indicates.
Researchers sought to evaluate the effect of MS on infant deliveries and birth outcomes among women who did not plan to undergo caesarean more »
by
All About MS
on Tue 23 May 2006 12:00 AM CST
New study findings suggest that patients with MS appear to experience a decline in mental functioning during the early stage of the disease.
To assess mental or cognitive impairments in the early stage of MS, researchers compared 21 MS patients with 22 subjects without MS. The patients with MS had experienced their first neurological symptom within more »
Monday, May 22
by
All About MS
on Mon 22 May 2006 01:00 AM CST
Socio-economic status may play role in differences of disability related to multiple sclerosis between black patients with MS and white patients with MS, a recent study finds.
In the trial, investigators sought to compare the differences in MS-related disability among 21,557 white and black patients with MS. All participants were more »
by
All About MS
on Mon 22 May 2006 12:00 AM CST
A new Danish study suggests that patients with multiple sclerosis may be more prone to fatal accidents than is the general population.
To compare the rate of fatal accidents of Danish patients with MS with people in the general population, researchers collected data from the Danish MS Registry and the Cause of Death Registry. A total of 10,174 subjects who had more »
Sunday, May 21
by
All About MS
on Sun 21 May 2006 02:00 AM CST
The study authors sought to determine the effect of a single exercise session on function, fatigue and sensory symptoms among 34 patients with MS. The session included strengthening, stretches and fitness exercise and lasted an average of more »
Saturday, May 20
by
All About MS
on Sat 20 May 2006 01:00 AM CST
A new method for blocking inflammatory signals in the brain could provide a means to preserve the myelin sheath that is damaged in patients with MS, according to research published in the May 10 issue of The Journal of Neuroscience.
Researchers at the University of Chicago had previously demonstrated that a chemical known as interferon-gamma not only prevented more »
Monday, May 15
by
All About MS
on Mon 15 May 2006 10:02 AM CST
The carnation is a flowering plant that has been cultivated for over 2000 years. I t is well known for both its beauty and long more »
|
||